2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Glycadia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects GLY-230, Placebo - Diabetic Nephropathy | Phase 1 / Phase 2 | Completed | Glycadia | 42 | 2007-02-01 | 2016-02-10 |
| Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects GLY-230, Placebo - Diabetes | Phase 1 | Completed | Glycadia | 54 | 2005-10-01 | 2016-02-10 |
Diabetes Mellitus (1) · Diabetic Nephropathies (1)
2-(3-chlorophenylamino)phenylacetic acid (2)
United States (1)
Laurence Kennedy (1) · Laurence Kennedy, M.D. (1) · Lis Cohen, D.O. (1) · Maria del Pilar Solano, M.D. (1)